Cargando…
Glucagon-like peptide-1 therapy and the exocrine pancreas: innocent bystander or friendly fire?
Autores principales: | Butler, P. C., Matveyenko, A. V., Dry, S., Bhushan, A., Elashoff, R. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2789933/ https://www.ncbi.nlm.nih.gov/pubmed/19894028 http://dx.doi.org/10.1007/s00125-009-1591-5 |
Ejemplares similares
-
Commensal Bacteria: Not Just Innocent Bystanders
por: Apicella, Michael A.
Publicado: (2019) -
Inflammation in the Alzheimer's disease cascade: culprit or innocent bystander?
por: Tan, Zaldy S, et al.
Publicado: (2010) -
Lipoprotein oxidation in cardiovascular disease: chief culprit or innocent bystander?
por: Heinecke, Jay W.
Publicado: (2006) -
Adipocytes in hematopoiesis and acute leukemia: friends, enemies, or innocent bystanders?
por: Zinngrebe, Julia, et al.
Publicado: (2020) -
Marked Expansion of Exocrine and Endocrine Pancreas With Incretin Therapy in Humans With Increased Exocrine Pancreas Dysplasia and the Potential for Glucagon-Producing Neuroendocrine Tumors
por: Butler, Alexandra E., et al.
Publicado: (2013)